title: Letter: can persisting liver stiffness indicate increased risk of HCC, after successful anti-HCV therapy?
authors.affiliation: Unit of Interdisciplinary Ultrasound, University of Leipzig, Leipzig, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Karlas
authors.affiliation: Section of Hepatology, University of Leipzig, Leipzig, Germany.
authors.forename: J
authors.initials: J
authors.lastname: Benckert
authors.affiliation: Unit of Interdisciplinary Ultrasound, University of Leipzig, Leipzig, Germany.
authors.forename: S
authors.initials: S
authors.lastname: Beer
authors.affiliation: Unit of Interdisciplinary Ultrasound, University of Leipzig, Leipzig, Germany.
authors.forename: V
authors.initials: V
authors.lastname: Keim
authors.affiliation: Section of Hepatology, University of Leipzig, Leipzig, Germany.
authors.forename: T
authors.initials: T
authors.lastname: Berg
authors.affiliation: Unit of Interdisciplinary Ultrasound, University of Leipzig, Leipzig, Germany. johannes.wiegand@medizin.uni-leipzig.de.|Section of Hepatology, University of Leipzig, Leipzig, Germany. johannes.wiegand@medizin.uni-leipzig.de.
authors.forename: J
authors.initials: J
authors.lastname: Wiegand
mesh_terms: D000998:Antiviral Agents / Q000627:therapeutic use*; D005260:Female; D019698:Hepatitis C, Chronic / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology*; D008099:Liver / Q000503:physiopathology*; D008103:Liver Cirrhosis / Q000188:drug therapy* / Q000209:etiology*; D008297:Male; D017082:Portal Pressure / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents